Ontology highlight
ABSTRACT:
SUBMITTER: EFPIA MID3 Workgroup
PROVIDER: S-EPMC4809625 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
Marshall S F SF Burghaus R R Cosson V V Cheung S Y A SY Chenel M M DellaPasqua O O Frey N N Hamrén B B Harnisch L L Ivanow F F Kerbusch T T Lippert J J Milligan P A PA Rohou S S Staab A A Steimer J L JL Tornøe C C Visser S A G SA
CPT: pharmacometrics & systems pharmacology 20160314 3
This document was developed to enable greater consistency in the practice, application, and documentation of Model-Informed Drug Discovery and Development (MID3) across the pharmaceutical industry. A collection of "good practice" recommendations are assembled here in order to minimize the heterogeneity in both the quality and content of MID3 implementation and documentation. The three major objectives of this white paper are to: i) inform company decision makers how the strategic integration of ...[more]